Biosimilars Regulatory Clinical And
Joanny Stroman
—
animal studies, and then clinical studies focusing on pharmacokinetics, pharmacodynamics, immunogenicity, and sometimes efficacy to confirm biosimilarity. What challenges exist in the biopharmaceutical development of biosimilars? Challenges include ensuring consistent manufacturing
